$SGMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 16 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Payment of Exercise | F | 15.85 | 1,252 | 19,844 | 12,233 | 13.5 K to 12.2 K (-9.28 %) |
| Dec 12 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Payment of Exercise | F | 16.90 | 2,348 | 39,681 | 13,485 | 15.8 K to 13.5 K (-14.83 %) |
| Dec 08 2017 | SGMO | SANGAMO THERAPEUTI ... | Conner Edward R. | Sr. VP & Chief Medi ... | Option Exercise | M | 3.20 | 5,000 | 16,000 | 195,000 | |
| Dec 08 2017 | SGMO | SANGAMO THERAPEUTI ... | Conner Edward R. | Sr. VP & Chief Medi ... | Sell | S | 16.24 | 5,000 | 81,200 | 0 | 5 K to 0 (-100.00 %) |
| Dec 08 2017 | SGMO | SANGAMO THERAPEUTI ... | Conner Edward R. | Sr. VP & Chief Medi ... | Buy | M | 3.20 | 5,000 | 16,000 | 5,000 | 0 to 5 K |
| Dec 06 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 12.12 | 11,803 | 143,052 | 8,197 | |
| Dec 06 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 18.00 | 11,803 | 212,454 | 15,833 | 27.6 K to 15.8 K (-42.71 %) |
| Dec 06 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 12.12 | 11,803 | 143,052 | 27,636 | 15.8 K to 27.6 K (+74.55 %) |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 8.87 | 416 | 3,690 | 4,168 | |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 9.41 | 781 | 7,349 | 19,532 | |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 9.41 | 13,433 | 126,405 | 20,313 | |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 16.70 | 3,197 | 53,390 | 15,833 | 19 K to 15.8 K (-16.80 %) |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 8.87 | 416 | 3,690 | 19,030 | 18.6 K to 19 K (+2.23 %) |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 9.41 | 781 | 7,349 | 18,614 | 17.8 K to 18.6 K (+4.38 %) |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 16.00 | 13,433 | 214,928 | 17,833 | 31.3 K to 17.8 K (-42.96 %) |
| Dec 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 9.41 | 13,433 | 126,405 | 31,266 | 17.8 K to 31.3 K (+75.33 %) |
| Nov 21 2017 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | M | 5.03 | 5,000 | 25,150 | 9,450 | |
| Nov 21 2017 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Sell | S | 14.67 | 5,000 | 73,339 | 0 | 5 K to 0 (-100.00 %) |
| Nov 21 2017 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Buy | M | 5.03 | 5,000 | 25,150 | 5,000 | 0 to 5 K |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 9.41 | 3,754 | 35,325 | 33,746 | |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 8.87 | 5,416 | 48,040 | 4,584 | |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 5.41 | 5,830 | 31,540 | 0 | |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 16.00 | 3,754 | 60,064 | 15,833 | 19.6 K to 15.8 K (-19.17 %) |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 9.41 | 3,754 | 35,325 | 19,587 | 15.8 K to 19.6 K (+23.71 %) |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 15.00 | 5,416 | 81,240 | 15,833 | 21.2 K to 15.8 K (-25.49 %) |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 8.87 | 5,416 | 48,040 | 21,249 | 15.8 K to 21.2 K (+34.21 %) |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 15.00 | 5,830 | 87,450 | 15,833 | 21.7 K to 15.8 K (-26.91 %) |
| Oct 04 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 5.41 | 5,830 | 31,540 | 21,663 | 15.8 K to 21.7 K (+36.82 %) |
| Sep 22 2017 | SGMO | SANGAMO THERAPEUTI ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.05 | 31,000 | 187,550 | 0 | |
| Sep 22 2017 | SGMO | SANGAMO THERAPEUTI ... | RINGO WILLIAM R | Director | Sell | S | 14.37 | 31,000 | 445,597 | 800 | 31.8 K to 800 (-97.48 %) |
| Sep 22 2017 | SGMO | SANGAMO THERAPEUTI ... | RINGO WILLIAM R | Director | Buy | M | 6.05 | 31,000 | 187,550 | 31,800 | 800 to 31.8 K (+3,875.00 %) |
| Sep 01 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 5.41 | 10,316 | 55,810 | 5,830 | |
| Sep 01 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 15.00 | 10,316 | 154,740 | 15,833 | 26.1 K to 15.8 K (-39.45 %) |
| Sep 01 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 5.41 | 10,316 | 55,810 | 26,149 | 15.8 K to 26.1 K (+65.16 %) |
| Sep 01 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 15.00 | 4,684 | 70,260 | 15,833 | 20.5 K to 15.8 K (-22.83 %) |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 5.12 | 5,000 | 25,600 | 0 | |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 2.55 | 3,000 | 7,650 | 0 | |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 3.99 | 3,474 | 13,861 | 0 | |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 11.00 | 5,000 | 55,000 | 20,517 | 25.5 K to 20.5 K (-19.59 %) |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 5.12 | 5,000 | 25,600 | 25,517 | 20.5 K to 25.5 K (+24.37 %) |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 10.00 | 6,474 | 64,740 | 20,517 | 27 K to 20.5 K (-23.99 %) |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 2.55 | 3,000 | 7,650 | 26,991 | 24 K to 27 K (+12.50 %) |
| Aug 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 3.99 | 3,474 | 13,861 | 23,991 | 20.5 K to 24 K (+16.93 %) |
| Jul 14 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Option Exercise | M | 3.99 | 172 | 686 | 3,474 | |
| Jul 14 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 10.00 | 14,828 | 148,280 | 20,517 | 35.3 K to 20.5 K (-41.95 %) |
| Jul 14 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Sell | S | 10.00 | 172 | 1,720 | 35,345 | 35.5 K to 35.3 K (-0.48 %) |
| Jul 14 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Sr.VP & Chief Busin ... | Buy | M | 3.99 | 172 | 686 | 35,517 | 35.3 K to 35.5 K (+0.49 %) |
| Jun 29 2017 | SGMO | SANGAMO THERAPEUTI ... | Zakrzewski Joseph S | Director | Option Exercise | A | 8.70 | 30,000 | 261,000 | 30,000 | |
| Jun 29 2017 | SGMO | SANGAMO THERAPEUTI ... | JEFFS ROGER | Director | Option Exercise | A | 8.70 | 30,000 | 261,000 | 30,000 | |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | Carey Robert | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | Mento Steven J | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | RINGO WILLIAM R | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Jun 02 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Senior VP & CBO | Sell | S | 6.80 | 2,000 | 13,600 | 35,345 | 37.3 K to 35.3 K (-5.36 %) |
| May 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Senior VP & CBO | Sell | S | 8.50 | 2,000 | 17,000 | 37,345 | 39.3 K to 37.3 K (-5.08 %) |
| May 15 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Senior VP & CBO | Sell | S | 6.50 | 639 | 4,154 | 39,345 | 40 K to 39.3 K (-1.60 %) |
| Mar 02 2017 | SGMO | SANGAMO THERAPEUTI ... | Yi Kathy | Senior VP & CFO | Option Exercise | A | 4.55 | 200,000 | 910,000 | 200,000 | |
| Jan 30 2017 | SGMO | SANGAMO THERAPEUTI ... | Macrae Sandy | President and CEO | Option Exercise | A | 3.50 | 360,000 | 1,260,000 | 360,000 | |
| Jan 30 2017 | SGMO | SANGAMO THERAPEUTI ... | Herberts Curt A. III | Senior VP & CBO | Option Exercise | A | 3.50 | 75,000 | 262,500 | 75,000 | |
| Dec 14 2016 | SGMO | SANGAMO BIOSCIENCE ... | Herberts Curt A. III | Senior VP & CBO | Payment of Exercise | F | 3.05 | 4,852 | 14,799 | 33,300 | 38.2 K to 33.3 K (-12.72 %) |
| Dec 14 2016 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 3.05 | 13,778 | 42,023 | 206,829 | 220.6 K to 206.8 K (-6.25 %) |
| Dec 02 2016 | SGMO | SANGAMO BIOSCIENCE ... | Conner Edward R. | Senior VP & CMO | Option Exercise | A | 3.20 | 200,000 | 640,000 | 200,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | A | 5.99 | 10,000 | 59,900 | 10,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | A | 5.99 | 10,000 | 59,900 | 10,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 5.99 | 10,000 | 59,900 | 10,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | A | 5.99 | 10,000 | 59,900 | 10,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | PARKER H STEWART | Director | Option Exercise | A | 5.99 | 10,000 | 59,900 | 10,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | A | 5.99 | 10,000 | 59,900 | 10,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | Director | Gift | G | 0.00 | 50,000 | 0 | 1,175,094 | 1.2 M to 1.2 M (-4.08 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | Director | Gift | G | 0.00 | 8,000 | 0 | 1,225,094 | 1.2 M to 1.2 M (-0.65 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | Director | Payment of Exercise | F | 6.23 | 16,107 | 100,347 | 148,691 | 164.8 K to 148.7 K (-9.77 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | Director | Payment of Exercise | F | 6.23 | 21,741 | 135,446 | 164,798 | 186.5 K to 164.8 K (-11.65 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | Director | Payment of Exercise | F | 6.23 | 21,741 | 135,446 | 186,539 | 208.3 K to 186.5 K (-10.44 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | Director | Payment of Exercise | F | 6.23 | 15,658 | 97,549 | 208,280 | 223.9 K to 208.3 K (-6.99 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | Director | Payment of Exercise | F | 6.23 | 9,395 | 58,531 | 223,938 | 233.3 K to 223.9 K (-4.03 %) |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | Carey Robert | Director | Option Exercise | A | 5.99 | 30,000 | 179,700 | 30,000 | |
| Jun 06 2016 | SGMO | SANGAMO BIOSCIENCE ... | Macrae Sandy | President and CEO | Option Exercise | A | 7.07 | 700,000 | 4,949,000 | 700,000 | |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 8.68 | 4,000 | 34,720 | 107,328 | 111.3 K to 107.3 K (-3.59 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 8.68 | 4,348 | 37,741 | 111,328 | 115.7 K to 111.3 K (-3.76 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Payment of Exercise | F | 8.68 | 13,045 | 113,231 | 293,906 | 307 K to 293.9 K (-4.25 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Payment of Exercise | F | 8.68 | 21,741 | 188,712 | 306,951 | 328.7 K to 307 K (-6.61 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 8.68 | 4,384 | 38,053 | 159,676 | 164.1 K to 159.7 K (-2.67 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 8.68 | 4,697 | 40,770 | 164,060 | 168.8 K to 164.1 K (-2.78 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 8.68 | 6,087 | 52,835 | 215,703 | 221.8 K to 215.7 K (-2.74 %) |
| Dec 15 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 8.68 | 6,522 | 56,611 | 221,790 | 228.3 K to 221.8 K (-2.86 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 9.41 | 50,000 | 470,500 | 50,000 | |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 9.69 | 6,087 | 58,983 | 115,676 | 121.8 K to 115.7 K (-5.00 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 25,000 | 0 | 121,763 | 96.8 K to 121.8 K (+25.84 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | A | 9.41 | 250,000 | 2,352,500 | 250,000 | |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Gift | G | 0.00 | 13,000 | 0 | 1,172,521 | 1.2 M to 1.2 M (-1.10 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Payment of Exercise | F | 9.69 | 31,308 | 303,375 | 328,692 | 360 K to 328.7 K (-8.70 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Grant | A | 0.00 | 125,000 | 0 | 360,000 | 235 K to 360 K (+53.19 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Option Exercise | A | 9.41 | 75,000 | 705,750 | 75,000 | |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 9.69 | 6,889 | 66,754 | 168,757 | 175.6 K to 168.8 K (-3.92 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Grant | A | 0.00 | 37,500 | 0 | 175,646 | 138.1 K to 175.6 K (+27.15 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | A | 9.41 | 75,000 | 705,750 | 75,000 | |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 9.69 | 7,060 | 68,411 | 228,312 | 235.4 K to 228.3 K (-3.00 %) |
| Dec 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Grant | A | 0.00 | 37,500 | 0 | 235,372 | 197.9 K to 235.4 K (+18.95 %) |
| Jul 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.82 | 25,000 | 170,500 | 25,000 | |
| Jul 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.43 | 25,000 | 260,770 | 235,000 | 260 K to 235 K (-9.62 %) |
| Jul 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.82 | 25,000 | 170,500 | 260,000 | 235 K to 260 K (+10.64 %) |
| Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 3,898 | 13,448 | 112,000 | |
| Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 6,102 | 21,052 | 115,898 | |
| Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 2,000 | 20,000 | 197,872 | 199.9 K to 197.9 K (-1.00 %) |
| Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 3,898 | 38,980 | 199,872 | 203.8 K to 199.9 K (-1.91 %) |
| Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 3,898 | 13,448 | 203,770 | 199.9 K to 203.8 K (+1.95 %) |
| Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 6,102 | 61,020 | 199,872 | 206 K to 199.9 K (-2.96 %) |
| Jul 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 6,102 | 21,052 | 205,974 | 199.9 K to 206 K (+3.05 %) |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | PARKER H STEWART | Director | Option Exercise | A | 11.44 | 10,000 | 114,400 | 10,000 | |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 11.44 | 10,000 | 114,400 | 10,000 | |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 11.44 | 10,000 | 114,400 | 10,000 | |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | A | 11.44 | 10,000 | 114,400 | 10,000 | |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 11.44 | 10,000 | 114,400 | 10,000 | |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | M | 11.44 | 10,000 | 114,400 | 10,000 | |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | M | 11.44 | 10,000 | 114,400 | 10,000 | |
| Jun 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.82 | 25,000 | 170,500 | 50,000 | |
| Jun 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 11.08 | 25,000 | 277,078 | 235,000 | 260 K to 235 K (-9.62 %) |
| Jun 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.82 | 25,000 | 170,500 | 260,000 | 235 K to 260 K (+10.64 %) |
| Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 122,000 | |
| Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.21 | 2,000 | 24,423 | 199,872 | 201.9 K to 199.9 K (-0.99 %) |
| Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.21 | 10,000 | 122,135 | 201,872 | 211.9 K to 201.9 K (-4.72 %) |
| Jun 12 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 211,872 | 201.9 K to 211.9 K (+4.95 %) |
| Jun 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 50,798 | |
| Jun 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.29 | 15,000 | 184,394 | 96,763 | 111.8 K to 96.8 K (-13.42 %) |
| Jun 09 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 15,000 | 51,750 | 111,763 | 96.8 K to 111.8 K (+15.50 %) |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.05 | 2,200 | 13,310 | 31,000 | |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Sell | S | 12.44 | 2,200 | 27,364 | 800 | 3 K to 800 (-73.33 %) |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Buy | M | 6.05 | 2,200 | 13,310 | 3,000 | 800 to 3 K (+275.00 %) |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.70 | 7,000 | 39,900 | 24,172 | |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 20,000 | |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 16,500 | |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 12.39 | 15,000 | 185,816 | 116,410 | 131.4 K to 116.4 K (-11.41 %) |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.70 | 7,000 | 39,900 | 131,410 | 124.4 K to 131.4 K (+5.63 %) |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,410 | 119.4 K to 124.4 K (+4.19 %) |
| Jun 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,410 | 116.4 K to 119.4 K (+2.58 %) |
| May 19 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.82 | 25,000 | 170,500 | 75,000 | |
| May 19 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 11.51 | 25,000 | 287,863 | 235,000 | 260 K to 235 K (-9.62 %) |
| May 19 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.82 | 25,000 | 170,500 | 260,000 | 235 K to 260 K (+10.64 %) |
| May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 132,000 | |
| May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 13.25 | 2,000 | 26,493 | 201,872 | 203.9 K to 201.9 K (-0.98 %) |
| May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 13.25 | 10,000 | 132,456 | 203,872 | 213.9 K to 203.9 K (-4.68 %) |
| May 13 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 213,872 | 203.9 K to 213.9 K (+4.91 %) |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 65,798 | |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.29 | 15,000 | 184,298 | 95,376 | 110.4 K to 95.4 K (-13.59 %) |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 15,000 | 51,750 | 110,376 | 95.4 K to 110.4 K (+15.73 %) |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.05 | 1,800 | 10,890 | 33,200 | |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.41 | 1,200 | 7,692 | 0 | |
| May 05 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Sell | S | 12.98 | 3,000 | 38,927 | 800 | 3.8 K to 800 (-78.95 %) |